Interim analysis of 2-years non-interventional trial (LARA) shows tendency towards higher treatment adherence with less compliant schizophrenia patients under long-acting injectable risperidone (LAIR) compared to an oral atypicals (OA) treatment cohort

Autor:	Andreas Schreiner, M. Gerwe, L. Hargarter, J. Czekalla, N. Klose, Bernd Ibach
Rok vydání:	2007
Předmět:	medicine.medical_specialty Risperidone Treatment adherence business.industry General Medicine Interim analysis medicine.disease Psychiatry and Mental health Long acting Schizophrenia Internal medicine Cohort Non interventional Physical therapy medicine Pharmacology (medical) business medicine.drug
Zdroj:	Pharmacopsychiatry. 40
ISSN:	1439-0795 0176-3679
DOI:	10.1055/s-2007-991745
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d640de5f0bebf2da63a417d4c7b9626e https://doi.org/10.1055/s-2007-991745 Zobrazit plný text záznamu